1-(3-Pentyl)piperazine → HCID 68805004, compound
Reaction equation
[Cl:1][CH2:2][C:3]1[CH:8]=[CH:7][C:6]([C:9]2[O:13][N:12]=[C:11]([CH2:14][CH:15]3[CH2:20][CH2:19][N:18]([CH:21]([CH2:24][CH3:25])[CH2:22][CH3:23])[CH2:17][CH2:16]3)[N:10]=2)=[CH:5][CH:4]=1.[CH2:26]([CH:28]([N:31]1[CH2:36][CH2:35][NH:34][CH2:33][CH2:32]1)[CH2:29][CH3:30])[CH3:27]>>[ClH:1].[ClH:1].[ClH:1].[CH2:26]([CH:28]([N:31]1[CH2:36][CH2:35][N:34]([CH2:2][C:3]2[CH:8]=[CH:7][C:6]([C:9]3[O:13][N:12]=[C:11]([CH2:14][CH:15]4[CH2:20][CH2:19][N:18]([CH:21]([CH2:24][CH3:25])[CH2:22][CH3:23])[CH2:17][CH2:16]4)[N:10]=3)=[CH:5][CH:4]=2)[CH2:33][CH2:32]1)[CH2:29][CH3:30])[CH3:27]Participants
3
Procedure
The title compound was prepared by a similar procedure to that described in Example 23, starting from 4-[5-(4-(chloromethyl)phenyl)-[1,2,4]oxadiazol-3-ylmethyl]-1-(1-ethylpropyl)piperidine and 1-(1-ethylpropyl)piperazine. HPLC: Rt=6.50 min.
Sources & evidence
- ORD record
- ord-f303a0ae377240eda4ac14a322b21597
- Source dataset
- uspto-grants-2010_09
- Patent number
- US07799924B2
Reaction notes
Loading…